Nathan B Fountain (Nathan Fountain)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Multidrug Resistant

Randomized Controlled Trial

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Nathan B Fountain, Mark Quigg, Charles F Murchison, Enrique Carrazana, Adrian L Rabinowicz
Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray. Epilepsia 65 (4) (2024)
Nathan B Fountain, Mark Quigg, Charles F Murchison, Enrique Carrazana, Adrian L Rabinowicz
Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray. Epilepsia 65 (4) (2024)
Nathan B Fountain, Mark Quigg, Charles F Murchison, Enrique Carrazana, Adrian L Rabinowicz
Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray. Epilepsia 65 (4) (2024)
Nathan B Fountain, Mark Quigg, Charles F Murchison, Enrique Carrazana, Adrian L Rabinowicz
Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray. Epilepsia (2024)
Vibhor Krishna, Jesse Mindel, Francesco Sammartino, Cady Block, Alok Kumar Dwivedi, Jamie J Van Gompel, Nathan B Fountain, Robert S Fisher
A phase 1 open-label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy. Epilepsia (2023)
Vibhor Krishna, Jesse Mindel, Francesco Sammartino, Cady Block, Alok Kumar Dwivedi, Jamie J Van Gompel, Nathan B Fountain, Robert S Fisher
A Phase-1 Open-label Trial Evaluating Focused Ultrasound Unilateral Anterior Thalamotomy for Focal Onset Epilepsy. Epilepsia (2023)
Stephanie M Ahrens, Kristen H Arredondo, Anto I Bagić, Shasha Bai, Kevin E Chapman, Michael A Ciliberto, Dave F Clarke, Mariah Eisner, Nathan B Fountain, Jay Raman Gavvala, Michael Scott Perry, Kyle C Rossi, Lily C Wong-Kisiel, Susan T Herman, Adam P Ostendorf, null null
Epilepsy center characteristics and geographic region influence presurgical testing in the United States. Epilepsia (2022)
Kristen H Arredondo, Stephanie M Ahrens, Anto I Bagic, Shasha Bai, Kevin E Chapman, Michael A Ciliberto, Dave F Clarke, Mariah Eisner, Nathan B Fountain, Jay Raman Gavvala, M S Perry, Kyle C Rossi, Lily C Wong-Kisiel, Susan T Herman, Adam P Ostendorf
Association Between Characteristics of National Association of Epilepsy Centers and Reported Utilization of Specific Surgical Techniques. Neurology (2022)
Jacqueline A French, Elena Cleary, Dennis Dlugos, Gail Farfel, Kathleen Farrell, Barry Gidal, Caitlin L Grzeskowiak, Rachel Gurrell, Cynthia Harden, Tracy J Stalvey, Julia Tsai, Elaine C Wirrell, David Blum, Nathan B Fountain
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years. Epilepsia 63 (10) (2022)
Abhishek G Sathe, Ellen Underwood, Lisa D Coles, Jordan J Elm, Robert S Silbergleit, James M Chamberlain, Jaideep Kapur, Hannah R Cock, Nathan B Fountain, Shlomo Shinnar, Daniel H Lowenstein, Eric S Rosenthal, Robin A Conwit, Thomas P Bleck, James C Cloyd
Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial. Epilepsia 62 (3) (2021)
Adam P Ostendorf, Stephanie M Ahrens, Fred Alexander Lado, Susan T Arnold, Shasha Bai, Meriem K Bensalem Owen, Kevin E Chapman, Dave F Clarke, Mariah Eisner, Nathan B Fountain, Johanna M Gray, Jennifer L Hopp, Ellen Riker, Stephan U Schuele, Barbara V Small, Susan T Herman
United States Epilepsy Center Characteristics: A Data Analysis From the National Association of Epilepsy Centers. Neurology (2021)
Abhishek G Sathe, Jordan J Elm, James C Cloyd, James M Chamberlain, Robert S Silbergleit, Jaideep Kapur, Hannah R Cock, Nathan B Fountain, Shlomo Shinnar, Daniel H Lowenstein, Robin A Conwit, Thomas P Bleck, Lisa D Coles
The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus. Epilepsia 61 (6) (2020)